Education
About Us
Working with TipRanks
Follow Us
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 42.28M | $ 0.00 | $ 458.00K | $ 40.00M | $ 0.00 |
| Gross Profit | $ 39.70M | $ -679.62K | $ 112.00K | $ 40.00M | $ -627.85K |
| Operating Income | $ -154.63M | $ -67.83M | $ -66.12M | $ -73.31M | $ -74.28M |
| EBITDA | $ -138.53M | $ -52.47M | $ -67.29M | $ -42.19M | $ -47.81M |
| Net Income | $ -173.42M | $ -54.37M | $ -68.70M | $ -55.57M | $ -65.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 399.76M | $ 271.77M | $ 227.83M | $ 148.38M | $ 187.99M |
| Total Assets | $ 474.24M | $ 308.12M | $ 259.47M | $ 186.59M | $ 204.21M |
| Total Debt | $ 2.36M | $ 51.33M | $ 10.65M | $ 5.81M | $ 5.95M |
| Net Debt | $ -397.40M | $ -220.44M | $ -217.18M | $ -142.57M | $ -182.04M |
| Total Liabilities | $ 269.68M | $ 58.84M | $ 29.00M | $ 38.58M | $ 19.35M |
| Stockholders' Equity | $ 204.56M | $ 249.28M | $ 230.47M | $ 148.00M | $ 184.85M |
| Cash Flow | |||||
| Free Cash Flow | $ -122.20M | $ -50.22M | $ -59.89M | $ -33.27M | $ -45.16M |
| Operating Cash Flow | $ -122.20M | $ -50.22M | $ -59.86M | $ -33.25M | $ -45.08M |
| Investing Cash Flow | $ -580.00K | $ 0.00 | $ -29.00K | $ -12.00K | $ 9.71M |
| Financing Cash Flow | $ 250.78M | $ 92.87M | $ 140.82M | $ -6.12M | $ 192.34M |